Oral contraceptives and colorectal cancer risk: A systematic review and meta-analysis

Cristina Bosetti, Francesca Bravi, Eva Negri, Carlo La Vecchia

Research output: Contribution to journalArticle

Abstract

Background: Various studies have reported an inverse relation between oral contraceptive (OC) use and the risk of colorectal cancer, but the issue is still open. Methods: In order to quantify the association between OC use and colorectal cancer risk, we performed a systematic review and meta-analysis of studies on this issue. We identified all relevant studies published, in English, as original articles up to December 2008 through a search of the literature using PubMed and EMBASE, and by reviewing the references from the retrieved articles. Results: The summary relative risk of colorectal cancer for ever versus never OC use was 0.82 (95% confidence interval, CI, 0.69-0.97) from 11 case-control studies, 0.81 (95% CI, 0.75-0.89) from seven cohort studies, and 0.81 (95% CI, 0.72-0.92) from all studies combined. The results were similar for colon and rectal cancer. No difference was evident according to duration of OC use both for colon and rectal cancer, although there is an indication that the protection is stronger for more recent use (OR = 0.70, 95% CI, 0.53-0.90, on the basis of four studies). Conclusion: Epidemiological data consistently indicate that OC users have a reduced risk of colorectal cancer, and that the protection is greater for recent use in the absence, however, of a duration-risk relation.

Original languageEnglish
Pages (from-to)489-498
Number of pages10
JournalHuman Reproduction Update
Volume15
Issue number5
DOIs
Publication statusPublished - 2009

Fingerprint

Mouth Neoplasms
Oral Contraceptives
Meta-Analysis
Colorectal Neoplasms
Rectal Neoplasms
Colonic Neoplasms
PubMed
Case-Control Studies
Cohort Studies
Confidence Intervals

Keywords

  • Colorectal cancer
  • Epidemiology
  • Meta-analysis
  • Oral contraceptives
  • Risk

ASJC Scopus subject areas

  • Obstetrics and Gynaecology
  • Reproductive Medicine

Cite this

Oral contraceptives and colorectal cancer risk : A systematic review and meta-analysis. / Bosetti, Cristina; Bravi, Francesca; Negri, Eva; La Vecchia, Carlo.

In: Human Reproduction Update, Vol. 15, No. 5, 2009, p. 489-498.

Research output: Contribution to journalArticle

Bosetti, Cristina ; Bravi, Francesca ; Negri, Eva ; La Vecchia, Carlo. / Oral contraceptives and colorectal cancer risk : A systematic review and meta-analysis. In: Human Reproduction Update. 2009 ; Vol. 15, No. 5. pp. 489-498.
@article{893ab2db138d481bb40bd58a68d6dcce,
title = "Oral contraceptives and colorectal cancer risk: A systematic review and meta-analysis",
abstract = "Background: Various studies have reported an inverse relation between oral contraceptive (OC) use and the risk of colorectal cancer, but the issue is still open. Methods: In order to quantify the association between OC use and colorectal cancer risk, we performed a systematic review and meta-analysis of studies on this issue. We identified all relevant studies published, in English, as original articles up to December 2008 through a search of the literature using PubMed and EMBASE, and by reviewing the references from the retrieved articles. Results: The summary relative risk of colorectal cancer for ever versus never OC use was 0.82 (95{\%} confidence interval, CI, 0.69-0.97) from 11 case-control studies, 0.81 (95{\%} CI, 0.75-0.89) from seven cohort studies, and 0.81 (95{\%} CI, 0.72-0.92) from all studies combined. The results were similar for colon and rectal cancer. No difference was evident according to duration of OC use both for colon and rectal cancer, although there is an indication that the protection is stronger for more recent use (OR = 0.70, 95{\%} CI, 0.53-0.90, on the basis of four studies). Conclusion: Epidemiological data consistently indicate that OC users have a reduced risk of colorectal cancer, and that the protection is greater for recent use in the absence, however, of a duration-risk relation.",
keywords = "Colorectal cancer, Epidemiology, Meta-analysis, Oral contraceptives, Risk",
author = "Cristina Bosetti and Francesca Bravi and Eva Negri and {La Vecchia}, Carlo",
year = "2009",
doi = "10.1093/humupd/dmp017",
language = "English",
volume = "15",
pages = "489--498",
journal = "Human Reproduction Update",
issn = "1355-4786",
publisher = "Oxford University Press",
number = "5",

}

TY - JOUR

T1 - Oral contraceptives and colorectal cancer risk

T2 - A systematic review and meta-analysis

AU - Bosetti, Cristina

AU - Bravi, Francesca

AU - Negri, Eva

AU - La Vecchia, Carlo

PY - 2009

Y1 - 2009

N2 - Background: Various studies have reported an inverse relation between oral contraceptive (OC) use and the risk of colorectal cancer, but the issue is still open. Methods: In order to quantify the association between OC use and colorectal cancer risk, we performed a systematic review and meta-analysis of studies on this issue. We identified all relevant studies published, in English, as original articles up to December 2008 through a search of the literature using PubMed and EMBASE, and by reviewing the references from the retrieved articles. Results: The summary relative risk of colorectal cancer for ever versus never OC use was 0.82 (95% confidence interval, CI, 0.69-0.97) from 11 case-control studies, 0.81 (95% CI, 0.75-0.89) from seven cohort studies, and 0.81 (95% CI, 0.72-0.92) from all studies combined. The results were similar for colon and rectal cancer. No difference was evident according to duration of OC use both for colon and rectal cancer, although there is an indication that the protection is stronger for more recent use (OR = 0.70, 95% CI, 0.53-0.90, on the basis of four studies). Conclusion: Epidemiological data consistently indicate that OC users have a reduced risk of colorectal cancer, and that the protection is greater for recent use in the absence, however, of a duration-risk relation.

AB - Background: Various studies have reported an inverse relation between oral contraceptive (OC) use and the risk of colorectal cancer, but the issue is still open. Methods: In order to quantify the association between OC use and colorectal cancer risk, we performed a systematic review and meta-analysis of studies on this issue. We identified all relevant studies published, in English, as original articles up to December 2008 through a search of the literature using PubMed and EMBASE, and by reviewing the references from the retrieved articles. Results: The summary relative risk of colorectal cancer for ever versus never OC use was 0.82 (95% confidence interval, CI, 0.69-0.97) from 11 case-control studies, 0.81 (95% CI, 0.75-0.89) from seven cohort studies, and 0.81 (95% CI, 0.72-0.92) from all studies combined. The results were similar for colon and rectal cancer. No difference was evident according to duration of OC use both for colon and rectal cancer, although there is an indication that the protection is stronger for more recent use (OR = 0.70, 95% CI, 0.53-0.90, on the basis of four studies). Conclusion: Epidemiological data consistently indicate that OC users have a reduced risk of colorectal cancer, and that the protection is greater for recent use in the absence, however, of a duration-risk relation.

KW - Colorectal cancer

KW - Epidemiology

KW - Meta-analysis

KW - Oral contraceptives

KW - Risk

UR - http://www.scopus.com/inward/record.url?scp=69049116296&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=69049116296&partnerID=8YFLogxK

U2 - 10.1093/humupd/dmp017

DO - 10.1093/humupd/dmp017

M3 - Article

C2 - 19414526

AN - SCOPUS:69049116296

VL - 15

SP - 489

EP - 498

JO - Human Reproduction Update

JF - Human Reproduction Update

SN - 1355-4786

IS - 5

ER -